Stocks and Investing
by (remove) : Joseph Catanzaro
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Joseph Catanzaro
RSSJSONXMLCSV
Mon, September 23, 2024
Tue, August 27, 2024
Mon, August 19, 2024
Wed, July 3, 2024
Fri, June 7, 2024
Thu, April 25, 2024
Mon, April 22, 2024
Fri, April 5, 2024
Mon, February 12, 2024
Fri, December 15, 2023
Tue, August 15, 2023
Fri, July 14, 2023
Mon, June 26, 2023
Tue, March 28, 2023
Mon, December 12, 2022
Wed, December 7, 2022
Thu, March 10, 2022
Wed, September 8, 2021
Tue, May 11, 2021
Mon, April 26, 2021
Mon, March 1, 2021

Joseph Catanzaro Maintained (BDTX) at Buy with Increased Target to $15 on, Sep 23rd, 2024


Published on 2024-10-28 14:25:12 - WOPRAI, Joseph Catanzaro
  Print publication without navigation


Joseph Catanzaro of Piper Sandler, Maintained "Black Diamond Therapeutics, Inc." (BDTX) at Buy with Increased Target from $12 to $15 on, Sep 23rd, 2024.

Joseph has made no other calls on BDTX in the last 4 months.



There are 3 other peers that have a rating on BDTX. Out of the 3 peers that are also analyzing BDTX, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Joseph


  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $11 on, Wednesday, September 18th, 2024
  • Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $16 on, Tuesday, September 10th, 2024
  • Laura Prendergast of "Raymond James" Initiated at Buy and Held Target at $20 on, Wednesday, July 31st, 2024
Contributing Sources